Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey H Sach

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
International Journal for Equity in Health|June 11, 2008
Equity in health care financing: The case of MalaysiaChai Ping Yu, David K Whynes, Tracey H Sach
The International Journal of Pharmacy Practice|November 8, 2014
Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older peopleTracey H Sach, James Desborough, Julie Houghton, et al.
Spine|February 5, 2008
ISSLS prize winner: cost-effectiveness of two forms of circumferential lumbar fusion: a prospective randomized controlled trialBrian J C Freeman, Nicholas A Steele, Tracey H Sach, et al.
Health and Quality of Life Outcomes|July 16, 2008
Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?Garry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Cost Effectiveness and Resource Allocation : C/E|July 21, 2009
Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee painGarry R Barton, Tracey H Sach, Anthony J Avery, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Lifestyle interventions for knee pain in overweight and obese adults aged > or = 45: economic evaluation of randomised controlled trialGarry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Medical Care|July 9, 2009
Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?Tracey H Sach, Garry R Barton, Claire Jenkinson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 3, 2007
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditionsGarry R Barton, Tracey H Sach, Michael Doherty, et al.
Plos Medicine|March 2, 2011
A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in childrenKim S Thomas, Tara Dean, Caroline O'Leary, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 5, 2025
Investigating the health economic burden of atopic disease in children from the EAT-On StudyRu-Xin Foong, Joanna Craven, George Du Toit, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
International Journal for Equity in Health|June 11, 2008
Equity in health care financing: The case of MalaysiaChai Ping Yu, David K Whynes, Tracey H Sach
The International Journal of Pharmacy Practice|November 8, 2014
Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older peopleTracey H Sach, James Desborough, Julie Houghton, et al.
Spine|February 5, 2008
ISSLS prize winner: cost-effectiveness of two forms of circumferential lumbar fusion: a prospective randomized controlled trialBrian J C Freeman, Nicholas A Steele, Tracey H Sach, et al.
Health and Quality of Life Outcomes|July 16, 2008
Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?Garry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Cost Effectiveness and Resource Allocation : C/E|July 21, 2009
Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee painGarry R Barton, Tracey H Sach, Anthony J Avery, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Lifestyle interventions for knee pain in overweight and obese adults aged > or = 45: economic evaluation of randomised controlled trialGarry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Medical Care|July 9, 2009
Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?Tracey H Sach, Garry R Barton, Claire Jenkinson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 3, 2007
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditionsGarry R Barton, Tracey H Sach, Michael Doherty, et al.
Plos Medicine|March 2, 2011
A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in childrenKim S Thomas, Tara Dean, Caroline O'Leary, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 5, 2025
Investigating the health economic burden of atopic disease in children from the EAT-On StudyRu-Xin Foong, Joanna Craven, George Du Toit, et al.
Pageof 6